CLINICAL_TRIALS
trial_result
· 2017-10-20
Clinical Trial Update: A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder [Phase 3]
Summary
Phase 3 long-term extension study of aripiprazole in pediatric patients with autistic disorder; results were posted after completion in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Autistic Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-10-20